Zobrazeno 1 - 10
of 312
pro vyhledávání: '"A. Affaitati"'
Autor:
Affaitati, Giannapia1 (AUTHOR) gpaffaitati@unich.it, Costantini, Raffaele2 (AUTHOR) raffaele.costantini@unich.it, Fiordaliso, Michele3 (AUTHOR) michele.fiordaliso@gmail.com, Giamberardino, Maria Adele4 (AUTHOR) mag@unich.it, Tana, Claudio5 (AUTHOR) claudio.tana@yahoo.it
Publikováno v:
Diagnostics (2075-4418). Aug2024, Vol. 14 Issue 16, p1750. 25p.
Autor:
Giannapia Affaitati, Raffaele Costantini, Michele Fiordaliso, Maria Adele Giamberardino, Claudio Tana
Publikováno v:
Diagnostics, Vol 14, Iss 16, p 1750 (2024)
Headache and visceral pain are common clinical painful conditions, which often co-exist in the same patients. Numbers relative to their co-occurrence suggest possible common pathophysiological mechanisms. The aim of the present narrative review is to
Externí odkaz:
https://doaj.org/article/9905ad3b1a394e78bcf44c1a77d8fa70
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Raffaele Ornello, Carlo Baraldi, Simona Guerzoni, Giorgio Lambru, Anna P. Andreou, Bianca Raffaelli, Astrid Gendolla, Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, Sabina Cevoli, Valentina Favoni, Fabrizio Vernieri, Claudia Altamura, Antonio Russo, Marcello Silvestro, Elisabetta Dalla Valle, Andrea Mancioli, Angelo Ranieri, Gennaro Alfieri, Nina Latysheva, Elena Filatova, Jamie Talbot, Shuli Cheng, Dagny Holle, Armin Scheffler, Tomáš Nežádal, Dana Čtrnáctá, Jitka Šípková, Zuzana Matoušová, Alfonsina Casalena, Maurizio Maddestra, Stefano Viola, Giannapia Affaitati, Maria Adele Giamberardino, Francesca Pistoia, Uwe Reuter, Simona Sacco
Publikováno v:
The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Background Monoclonal antibodies acting on the calcitonin gene-related peptide (CGRP) or its receptor have changed migraine preventive treatment. Those treatments have led to reconsidering the outcomes of migraine prevention. Available data
Externí odkaz:
https://doaj.org/article/62e111c3fc11417ba73c91df8a1fe766
Autor:
Eleonora De Matteis, Valeria Caponnetto, Alfonsina Casalena, Ilaria Frattale, Amleto Gabriele, Giannapia Affaitati, Maria Adele Giamberardino, Maurizio Maddestra, Stefano Viola, Francesca Pistoia, Simona Sacco, Raffaele Ornello
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
ObjectiveCranial autonomic symptoms (CAS), including conjunctival injection, tearing, nasal congestion or rhinorrhea, eyelid edema, miosis or ptosis, and forehead or facial sweating ipsilateral to headache, are often reported by patients with migrain
Externí odkaz:
https://doaj.org/article/f34b9911a7e54e5b95195d86bc1a11f1
Autor:
Ilaria Frattale, Valeria Caponnetto, Alfonsina Casalena, Maurizio Assetta, Maurizio Maddestra, Fabio Marzoli, Giannapia Affaitati, Maria Adele Giamberardino, Stefano Viola, Amleto Gabriele, Francesca Pistoia, Davide Cerone, Carmine Marini, Simona Sacco, Raffaele Ornello
Publikováno v:
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-6 (2021)
Abstract Background Triptans and erenumab are both migraine-specific agents acting on the calcitonin gene-related peptide pathway. Therefore, response to triptans might be associated with response to erenumab. Main body In our study, consecutive pati
Externí odkaz:
https://doaj.org/article/27c34b0e1b9442d6a2a7ed223f8ab26c
Autor:
Raffaele Ornello, Alfonsina Casalena, Ilaria Frattale, Valeria Caponnetto, Amleto Gabriele, Giannapia Affaitati, Maria Adele Giamberardino, Maurizio Assetta, Maurizio Maddestra, Fabio Marzoli, Stefano Viola, Davide Cerone, Carmine Marini, Francesca Pistoia, Simona Sacco
Publikováno v:
The Journal of Headache and Pain, Vol 21, Iss 1, Pp 1-7 (2020)
Abstract Background Most patients treated with erenumab in clinical practice have chronic migraine (CM). We assessed the rate and possible predictors of conversion from CM to episodic migraine (EM) in a real-life study. Main body We performed a subgr
Externí odkaz:
https://doaj.org/article/0a2ef149b15a4f6d88e5f6172094cc45
Autor:
Raffaele Ornello, Alfonsina Casalena, Ilaria Frattale, Amleto Gabriele, Giannapia Affaitati, Maria Adele Giamberardino, Maurizio Assetta, Maurizio Maddestra, Fabio Marzoli, Stefano Viola, Davide Cerone, Carmine Marini, Francesca Pistoia, Simona Sacco
Publikováno v:
The Journal of Headache and Pain, Vol 21, Iss 1, Pp 1-11 (2020)
Abstract Background We aimed to assess the efficacy and safety of erenumab, a fully human monoclonal antibody inhibiting the calcitonin gene-related peptide receptor (CGRPr), for the prevention of migraine in a real-life setting. Main body We include
Externí odkaz:
https://doaj.org/article/2ebf80aef9604e619f8404467e740ae6
Autor:
Raffaele Ornello, Carlo Baraldi, Simona Guerzoni, Giorgio Lambru, Matteo Fuccaro, Bianca Raffaelli, Astrid Gendolla, Piero Barbanti, Cinzia Aurilia, Sabina Cevoli, Valentina Favoni, Fabrizio Vernieri, Claudia Altamura, Antonio Russo, Marcello Silvestro, Elisabetta Dalla Valle, Andrea Mancioli, Angelo Ranieri, Gennaro Alfieri, Nina Latysheva, Elena Filatova, Jamie Talbot, Shuli Cheng, Dagny Holle, Armin Scheffler, Tomáš Nežádal, Dana Čtrnáctá, Jitka Šípková, Zuzana Matoušová, Lucia Sette, Alfonsina Casalena, Maurizio Maddestra, Stefano Viola, Giannapia Affaitati, Maria Adele Giamberardino, Francesca Pistoia, Uwe Reuter, Simona Sacco
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Objective: We reported gender-specific data on the efficacy and safety of erenumab, a monoclonal antibody antagonizing the calcitonin gene-related peptide (CGRP) receptor.Methods: Our pooled patient-level analysis of real-world data included patients
Externí odkaz:
https://doaj.org/article/15f9c2554d6c4e1285b954009539d925
Autor:
Giannapia Affaitati, Raffaele Costantini, Claudio Tana, Domenico Lapenna, Cosima Schiavone, Francesco Cipollone, Maria Adele Giamberardino
Publikováno v:
The Journal of Headache and Pain, Vol 19, Iss 1, Pp 1-10 (2018)
Abstract Background In migraine patients with cervical myofascial trigger points whose target areas coincide with migraine sites (M + cTrPs), TrP anesthetic injection reduces migraine symptoms, but the procedure often causes discomfort. This study ev
Externí odkaz:
https://doaj.org/article/7516fe056f9c4184a642cc978e89c184